Combination treatment with normobaric hyperoxia and cilostazol protects mice against focal cerebral ischemia-induced neuronal damage better than each treatment alone

Nonaka, Y; Koumura, A; Hyakkoku, K; Shimazawa, M; Yoshimura, S; Iwama, T; Hara, H

HERO ID

891128

Reference Type

Journal Article

Year

2009

Language

English

PMID

19336663

HERO ID 891128
In Press No
Year 2009
Title Combination treatment with normobaric hyperoxia and cilostazol protects mice against focal cerebral ischemia-induced neuronal damage better than each treatment alone
Authors Nonaka, Y; Koumura, A; Hyakkoku, K; Shimazawa, M; Yoshimura, S; Iwama, T; Hara, H
Journal Journal of Pharmacology and Experimental Therapeutics
Volume 330
Issue 1
Page Numbers 13-22
Abstract Normobaric hyperoxia (NBO) and cilostazol (6-[4-(1-cyclohexy-1H-tetrazol-5-yl)butoxyl]-3,4-dihydro-2-(1H)-quinolinone) (a selective inhibitor of phosphodiesterase 3) have each been reported to exert neuroprotective effects against acute brain injury after cerebral ischemia in rodents. Here, we evaluated the potential neuroprotective effects of combination treatment with NBO and cilostazol against acute and subacute brain injuries after simulated stroke. Mice subjected to 2-h filamental middle cerebral artery (MCA) occlusion were treated with NBO (95% O(2), during the ischemia) alone, with cilostazol (3 mg/kg i.p. after the ischemia) alone, with both of these treatments (combination), or with vehicle. The histological and neurobehavioral outcomes were assessed at acute (1 day) or subacute (7 days) stages after reperfusion. We measured regional cerebral blood flow (rCBF) during and after ischemia by laser-Doppler flowmetry and recovery (versus vehicle) in the combination therapy group just after reperfusion. Mean acute and subacute lesion volumes were significantly reduced in the combination group but not in the two monotherapy groups. The combination therapy increased endothelial nitric-oxide synthase (eNOS) activity in the lesion area after ischemia versus vehicle. Combination therapy with NBO plus cilostazol protected mice subjected to focal cerebral ischemia by improvement of rCBF after reperfusion, in part in association with eNOS activity.
Doi 10.1124/jpet.109.151548
Pmid 19336663
Wosid WOS:000267280300002
Is Certified Translation No
Dupe Override No
Is Public Yes
Language Text English
Is Qa No